Premature mortality due to prostate cancer in Pinar del Río. 2015-2019
Keywords:
PROSTATIC NEOPLASMS, NATIONAL HEALTH PROGRAMS, AGE GROUPS, POTENTIAL YEARS OF LIFE LOST, MORTALITY, PREMATURE.Abstract
Introduction: prostate cancer is a malignant neoplasm of the epithelial tissue. It constitutes a worldwide health problem and in many developed countries it represents the most commonly diagnosed cancer in men.
Objective: to determine the trend of premature mortality due to prostate cancer in Pinar del Rio province during the period 2015-2019.
Methods: an observational, descriptive and retrospective study of the total number of premature deaths (72) due to this neoplasm was carried out, for this purpose; this trend was analyzed through descriptive statistics and meeting medical ethics. Data were obtained from the Mortality Registry of the Provincial Office of Public Health in Pinar del Rio.
Results: the age group 65-69 years old predominated with 58,33 %. The linear trend of mortality was downward with 2015 being the predominant year. Pinar del Rio municipality stood out with 26 premature deaths and 132 potential years of life lost; however, the highest risk of premature death due to prostate cancer was in San Juan y Martínez municipality and Minas de Matahambre municipality stood out as the average number of years lost with 13 years.
Conclusions: there was a trend towards a decrease in premature mortality rate due to prostate cancer.
Downloads
References
1. Valdés-Villafranca R, Ramos-Cordero A, Valiente-Morejón W, Junco-Sena B, Valdés-Villafranca R. Mortalidad prematura según causas seleccionadas en el Policlínico “5 de septiembreˮ. Rev. cuban. med. gen. integr. [Internet]. 2021 [Citado: 06/01/2021]; 37(3) Disponible en: http://revmgi.sld.cu/index.php/mgi/article/view/1472
2. Análisis De Situación De Salud (ASIS) Colombia, 2017. Dirección de Epidemiología y Demografía Bogotá. [Internet]. 2018. [Citado: 06/01/2021]; Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/asis-nacional-2017.pdf
3. García-Perdomo HA, Zapata-Copete JA, Sánchez A. Una mirada global y actualizada del cáncer de próstata. Rev. Fac. Med. [Internet]. 2018 [Citado: 06/01/2021]; 66(3): 429-37. Disponible en: http://www.scielo.org.co/pdf/rfmun/v66n3/0120-0011-rfmun-66-03-429.pdf
4. Savón Moiran L. Cáncer de próstata: actualización. Rev. inf. cient. [Internet]. 2019 Feb [Citado: 06/01/2021]; 98(1): 117-126. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1028-99332019000100117&Ing=es.
5. Anuario Estadístico de Salud 2019. La Habana. [Internet]. 2020. [Citado: 06/01/2021]; Disponible en: https://files.sld.cu/bvscuba/files/2020/05/Anuario-Electrónico-Español-2019-ed-2020.pdf
6. Soler Santana R, Brossard Cisnero M, Suárez Ramírez N, Alcaraz Martínez M. Perfil de mortalidad en la provincia de Santiago de Cuba durante 2017. MEDISAN [Internet]. 2018 Dic [Citado: 06/01/2021]; 22(9): 897-908. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192018000900897&lng=es.
7. Cáncer de Próstata. Winship Cancer Institute of Emory University. [Internet]. 2020. [Citado: 06/01/2021]; Disponible en: https://www.cancerquest.org/es/para-los-pacientes/cancer-por-tipo/cancer-de-prostata?gclid=EAIaIQobChMI2brIt6Cg6gIVw9SzCh1dhgfdEAAYASAAEgJ9vPD_BwE
8. Ruiz López AI, Pérez Mesa JC, Cruz Batista Y, González Lorenzo LE. Actualización sobre cáncer de próstata. ccm [Internet]. 2017 [Citado: 06/01/2021]; 21(3): 876-887. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812017000300021&lng=es.
9. Anuario Estadístico de Salud 2018. Pinar del Río. Oficina Nacional de Estadística e Información. [Internet]. 2019 [Citado: 06/01/2021]; Disponible en: http://www.onei.gob.cu/sites/default/files/anuario_est_provincial/00_anuario_completo_2018.pdf
10. Sagué Larrea JL, Franco Camejo L, Doimeadios Rodríguez Z. Análisis de la mortalidad por cáncer de próstata en pacientes de la provincia de Holguín. ccm [Internet]. 2017 Mar [Citado: 06/01/2021]; 21(1): 33-43. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812017000100004&lng=es.
11. Mirzaei M, Mahboobehsadat M, Mohsen M. Mortality Rate and Years of Life Lost Due to Prostate Cancer in Yazd Province, Iran: A 10-year study. Sultan Qaboos Univ Med J. [Internet]. 2017 [Citado: 06/01/2021]; 17(4): e424-e429. Disponible en: https://www.ncbi.nlm.nih.gov/m/pubmed/29372084/
12. Carga de mortalidad de enfermedades no transmisibles en la población igual o mayor de 20 años de El Salvador 2011 – 2015. Instituto Nacional de Salud, El Salvador. [Internet]. 2017 [Citado: 06/01/2021]. Disponible en: http://ins.salud.gob.sv/wp-content/uploads/2018/07/Carga-de-mortalidad-de-enfermedades-no-transmisibles.pdf
13. Ramos Fullá O. J, Mercado C. A. Detección precoz de cáncer de próstata: Controversias y recomendaciones actuales. REV. MÉD. CLÍN. CONDES. [Internet]. 2018 [Citado: 06/01/2021]; 29(2): 128-135. Disponible en: https://doi.org/10.1016/j.rmclc.2018.02.013.
14. Documento-Seguimiento a las Acciones Programadas en el Nivel Nacional y Territorial, para el Logro de la Megameta en Salud. MINSALUD. Colombia. [Internet]. 2017 [Citado: 06/01/2021]. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/seguimiento-megameta-1er-semestre-2017.pdf
15. World Health Organization. Cáncer de próstata (c61) en Uruguay[Internet]. 2018 [Citado: 06/01/2021]. Disponible en: https://www.comisioncancer.org.uy/Ocultas/Incidencia-y-Mortalidad-2013-2017-Distribucion-por-rango-etario--uc280
16. Bejarano M. Impacto de la mortalidad por cáncer. Rev Colomb Cir. [Internet]. 2018. [Citado: 06/01/2021]; 33(4): 338-9. Disponible en: https://doi.org/10.30944/20117582.79
17. Navarrete-Valero C, Navarrete-Vázquez C. Mortalidad por cáncer mamario, prostático y cervicouterino, años perdidos y costos de los programas. México, 2013 a 2016. Gaceta Médica de México. Gac Med Mex. [Internet]. 2018 [Citado: 06/01/2021]; 154:665-670. Disponible en: https://www.anmm.org.mx/GMM/2018/n6/GMM_6_18_665-670.pdf
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
